ClinicalTrials.govpublic full text
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
non small cell lung cancer (nsclc), cetuximab, non small cell lung cancer, lung cancer, cisplatin/vinorelbine, monoclonal antibody, erbitux, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912538
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.